(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -2.00%3.36B | -6.93%1.54B | -6.66%6.69B | -3.13%5.05B | 3.82%3.43B | 9.40%1.65B | 75.61%7.17B | 78.66%5.21B | 82.65%3.3B | 90.17%1.51B |
Operating income | -2.00%3.36B | -6.93%1.54B | -6.66%6.69B | -3.13%5.05B | 3.82%3.43B | 9.40%1.65B | 75.61%7.17B | 78.66%5.21B | 82.65%3.3B | 90.17%1.51B |
Cost of sales | -6.21%-3.07B | ---- | 6.55%-5.61B | ---- | -10.10%-2.89B | ---- | -89.76%-6.01B | ---- | -92.51%-2.63B | ---- |
Operating expenses | -6.21%-3.07B | 1.22%-1.38B | 6.55%-5.61B | 0.76%-4.21B | -10.10%-2.89B | -15.01%-1.4B | -89.76%-6.01B | -88.59%-4.24B | -92.51%-2.63B | -106.43%-1.22B |
Gross profit | -46.00%291.2M | -38.68%154.22M | -7.26%1.07B | -13.50%837.82M | -20.49%539.21M | -13.94%251.5M | 26.68%1.16B | 45.15%968.62M | 52.41%678.2M | 43.21%292.23M |
Selling expenses | -143.00%-25.62M | -3.90%-10.59M | 2.84%-35.08M | 18.72%-21.23M | 48.77%-10.54M | -64.97%-10.19M | -44.60%-36.11M | -53.86%-26.12M | -63.89%-20.58M | 31.28%-6.18M |
Administrative expenses | -11.36%-79.81M | -77.87%-40.53M | -6.84%-184.27M | 20.57%-92.65M | 25.68%-71.67M | 37.28%-22.79M | -8.06%-172.48M | 5.99%-116.64M | -9.31%-96.43M | 5.04%-36.33M |
Research and development expenses | 12.54%-152.84M | -3.84%-74.59M | -4.86%-353.88M | -15.99%-256.43M | -24.24%-174.75M | -22.10%-71.83M | -110.71%-337.48M | -116.72%-221.08M | -80.10%-140.66M | -81.55%-58.83M |
Profit from asset sales | ---- | 590.90%256.97K | ---- | -177.60%-311.74K | ---- | -85.05%37.19K | ---- | -22.61%401.72K | ---- | --248.85K |
Revaluation surplus | ---- | ---- | ---- | 678.33%10.44M | ---- | -32.43%2.25M | ---- | -156.63%-1.81M | ---- | -26.29%3.33M |
-Changes in the fair value of other assets | ---- | ---- | ---- | 678.33%10.44M | ---- | -32.43%2.25M | ---- | -156.63%-1.81M | ---- | -26.29%3.33M |
Impairment and provision | -78.64%-22.25M | -136.93%-14.83M | -7.48%-23.88M | 4.20%-20.8M | 16.71%-12.45M | 9.17%-6.26M | -171.61%-22.22M | -312.24%-21.72M | -326.56%-14.95M | -33,693.19%-6.89M |
-Other impairment is provision | -78.64%-22.25M | -136.93%-14.83M | -7.48%-23.88M | 4.20%-20.8M | 16.71%-12.45M | 9.17%-6.26M | -171.61%-22.22M | -312.24%-21.72M | -326.56%-14.95M | -33,693.19%-6.89M |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.81%-34.71M | ---- |
Special items of operating profit | 55.41%141.98M | 45.22%90.42M | 150.23%157.2M | 163.37%56.21M | -39.84%91.36M | 564.61%62.26M | 100.54%62.82M | 20.37%21.34M | 597.44%151.87M | 41.11%9.37M |
Operating profit | -57.73%152.67M | -49.57%100.05M | -2.84%635.01M | -15.31%495.01M | -30.91%361.16M | 4.84%198.41M | 26.76%653.58M | 36.18%584.52M | 109.61%522.74M | 42.76%189.25M |
Financing cost | 6.43%-26.12M | 295.31%14.61M | 25.26%-51.48M | -73.58%42.06M | ---27.92M | -22.55%-7.48M | ---68.88M | 638.33%159.24M | ---- | 70.45%-6.1M |
Share of profits of associates | 183.05%501K | ---- | 129.97%386K | ---- | 296.67%177K | ---- | 59.69%-1.29M | ---- | 96.04%-90K | ---- |
Special items of earning before tax | -101.29%-364K | 100.86%7.63K | -81.97%33.04M | -145.08%-1.71M | --28.21M | -173.02%-882.84K | --183.29M | -439.53%-698.97K | ---- | 18.64%-323.37K |
Earning before tax | -64.97%126.68M | -39.67%114.66M | -19.53%616.96M | -27.95%535.36M | -30.81%361.63M | 3.95%190.04M | 49.62%766.7M | 85.83%743.05M | 111.50%522.65M | 63.94%182.82M |
Tax | 78.52%-5.94M | -11.23%-12.47M | 19.38%-50.08M | 30.47%-38.37M | 52.93%-27.64M | 40.42%-11.21M | -6.27%-62.11M | -15.20%-55.19M | -121.30%-58.71M | -91.72%-18.81M |
After-tax profit from continuing operations | -63.85%120.75M | -42.86%102.19M | -19.54%566.88M | -27.75%496.99M | -28.01%334M | 9.04%178.83M | 55.20%704.59M | 95.45%687.86M | 110.32%463.94M | 61.26%164.01M |
Earning after tax | -63.85%120.75M | -42.86%102.19M | -19.54%566.88M | -27.75%496.99M | -28.01%334M | 9.04%178.83M | 55.20%704.59M | 95.45%687.86M | 110.32%463.94M | 61.26%164.01M |
Minority profit | -23.28%1.07M | -20.56%500.76K | 67.86%3.19M | 140.79%2.72M | 1,188.89%1.39M | 249.50%630.34K | 153.07%1.9M | 118.58%1.13M | -55.19%108K | -40.65%180.36K |
Profit attributable to shareholders | -64.02%119.68M | -42.93%101.69M | -19.78%563.69M | -28.03%494.27M | -28.29%332.6M | 8.77%178.2M | 55.04%702.69M | 95.41%686.73M | 110.51%463.83M | 61.57%163.83M |
Basic earnings per share | -64.00%0.09 | -38.46%0.08 | -20.75%0.42 | -29.42%0.3683 | -54.55%0.25 | -38.10%0.13 | -18.46%0.53 | 2.62%0.5218 | 71.88%0.55 | 40.00%0.21 |
Diluted earnings per share | -64.00%0.09 | -38.46%0.08 | -19.23%0.42 | -29.42%0.3683 | -54.55%0.25 | -38.10%0.13 | -20.00%0.52 | 2.62%0.5218 | 71.88%0.55 | 40.00%0.21 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data